High-energy, Low-protein Renalive LP for CKD patients with reduced kidney function

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial will use Renalive LP as the intervention for adults with CKD stages 3b-5 and a history of eGFR below 45 mL/min/1.73 m2. Participants who have not started dialysis and are not expected to begin within three months are included. The study will monitor nutritional status and safety to determine if the formula supports better calorie intake with lower protein. No comparator is specified in the available information. The lead sponsor is Fresenius Kabi Taiwan Ltd., with studies conducted at two hospitals in Taiwan.

Why it matters

Who can join: the full rules

Inclusion Criteria:

(1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2)

Exclusion Criteria:

(1) Has received dialysis or are expected to start dialysis within the next 3 months

Where it's running

• Kaosiung Chang Gung Memorial Hospital
  Kaohsiung City, Taiwan Recruiting
• Taipei TzuChi Hospital
  New Taipei City, Taiwan Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping

  This project tests a Renal dining map app to help CKD patients in Singapore choose foods when dining out and see if it improves empowerment and well‑being.

  Recruiting Singapore Institute of Technology · Singapore · NCT07804316

• Self-Management Data and Disease Progression in CKD

  This study tests whether patient-recorded self-management data collected via a mobile app can be linked to CKD progression in adults seen at a university hospital.

  Recruiting Chungnam National University Hospital · Daejeon, DJ · NCT07754097

• Enarodustat for Anemia in Non-Dialysis CKD Patients

  This study tests whether enarodustat can help increase hemoglobin safely in adults with CKD who aren’t on dialysis, grouping participants by inflammation level.

  Recruiting Huashan Hospital · Shanghai, Shanghai Municipality · NCT07741279

• Adequacy of Middle Molecules Clearance in Haemodiafiltration and its Relation to Patient Outcomes

  This study looks at whether higher convective volumes in haemodiafiltration and different dialysate sodium levels affect toxin clearance, patient-reported outcomes, and nutritional status in adults with end-stage kidney disease.

  Recruiting East and North Hertfordshire NHS Trust · Stevenage, Hertfordshire · NCT07717255

• Periodontal Health in Rare Kidney Conditions and Controls

  This study tests how common periodontitis is in people with rare kidney disorders and compares it to CKD patients and people without kidney disease.

  Recruiting Institutul Clinic Fundeni · Bucharest · NCT07575347

• AdiaVita regenerative therapy for chronic kidney disease

  This trial tests whether AdiaVita (umbilical cord blood stem cells and exosomes plus glutathione) can improve kidney function in adults with stage 2–4 chronic kidney disease.

  Recruiting Phase 1 Adia Med of Winter Park LLC · Winter Park, Florida · NCT07572890

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.